483 Corixa dba GlaxoSmithKline Vaccines May 2017

483 Corixa dba GlaxoSmithKline Vaccines May 2017

Michele Forster FDA$119.00 - Available Now

FDA investigators audited the Corixa dba GlaxoSmithKline Vaccines - Marietta, PA, United States facility and issued inspectional observations (via FDA 483) on 16 May 2017.

Product details

  • Category: Biologics
  • Inspection end: 16 May 2017
  • Location: Marietta, United States
  • FEI: 3007726770
Add To Cart